(Q39432208)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Adele Vivacqua

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sergio Abonante

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Enrica Romeo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Paola De Marco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ernestina Marianna De Francesco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

English

0 references

publication date

7 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

133

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1025-1035

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-011-1901-8

18 January 2020

exact match

0 references

cites work

Immediate-early genes: ten years on.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

DNA binding site of the growth factor-inducible protein Zif268

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Is EGR1 a potential target for prostate cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Induction of the early growth response (Egr) family of transcription factors during thymic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Hypoxia-associated induction of early growth response-1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Granulocyte colony-stimulating factor induces Egr-1 up-regulation through interaction of serum response element-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase 2-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Early growth response-1-dependent apoptosis is mediated by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Uterine temporal response to acute exposure to 17alpha-ethinyl estradiol in the immature rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Estrogen activates raf-1 kinase and induces expression of Egr-1 in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Egr-1 is activated by 17beta-estradiol in MCF-7 cells by mitogen-activated protein kinase-dependent phosphorylation of ELK-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Minireview: Cyclin D1: normal and abnormal functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through beta-catenin-T-cell factor/Lef signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Expression of connective tissue growth factor (CTGF/CCN2) in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

A multigenic program mediating breast cancer metastasis to bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Cyclins: roles in mitogenic signaling and oncogenic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Connective tissue growth factor (CTGF) and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

21 January 2018

Fibroblasts in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Breast cancer: origins and evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Mechanisms of estrogen signaling and gene expression via GPR30

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

The unfolding stories of GPR30, a new membrane-bound estrogen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Antihormones in prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Estrogen receptor mutations in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

Stromal fibroblasts in cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1901-8

10.1007/S10549-011-1901-8

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147081%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference